Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.1600-0.0500 (-1.19%)
At close: 04:00PM EDT
4.2200 +0.06 (+1.44%)
Pre-market: 08:36AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
110,643
304,767
504,389
272,127
Other short-term investments
278,344
119,543
3,212
28,239
Total cash
388,987
424,310
507,601
300,366
Net receivables
56,950
50,599
29,413
8,646
Inventory
28,683
27,533
15,791
7,039
Other current assets
19,542
12,586
9,986
5,528
Total current assets
495,966
516,500
566,136
323,800
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
19,120
18,167
23,299
14,449
Accumulated depreciation
-11,210
-9,550
-8,113
-7,336
Net property, plant and equipment
7,910
8,617
15,186
7,113
Equity and other investments
0
18,077
6,829
-
Other long-term assets
13,084
6,806
6,472
3,802
Total non-current assets
20,994
33,500
22,015
10,915
Total assets
516,960
550,000
588,151
334,715
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
30,000
Accounts payable
20,893
14,356
27,808
18,713
Accrued liabilities
21,331
43,408
38,991
44,500
Deferred revenues
0
1,224
1,421
150
Other current liabilities
23,565
-
-
-
Total current liabilities
149,988
105,514
103,718
105,654
Non-current liabilities
Long-term debt
811,265
733,279
585,457
244,452
Total non-current liabilities
822,500
739,083
591,419
248,323
Total liabilities
972,488
844,597
695,137
353,977
Stockholders' equity
Common stock
2,058
1,879
1,843
1,769
Retained earnings
-1,681,159
-1,454,620
-1,207,504
-1,023,442
Accumulated other comprehensive income
1,337
26
177
3
Total stockholders' equity
-455,528
-294,597
-106,986
-19,262
Total liabilities and stockholders' equity
516,960
550,000
588,151
334,715